ipilimumab,Aldesleukin
bms
['melanoma']
suzanne phillips presented a phase ib trial of endogenous t cell therapy using slc45a2-specific cd8 t cells for patients with metastatic uveal melanoma (9588). #asco23 #endcancer 2/4 
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Appointments available: 1-877-632-6789